Informed Consent
Item
provision of written inform consent
boolean
C0021430 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosed of major depressive disorder based on dsm-iv-tr
boolean
C1269683 (UMLS CUI [1])
Outpatients | Pharmacotherapy Plan Change | Status post Partial response | Intolerance to Antidepressive Agents Dosage | Intolerance to Selective Serotonin Reuptake Inhibitors | Intolerance to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Item
outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (ssri/nsri) 5
boolean
C0029921 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0443172 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C1521726 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0003289 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C1744706 (UMLS CUI [5,1])
C0360105 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C1579361 (UMLS CUI [6,2])
Protocol Compliance
Item
able to understand and to comply with requirements of the study
boolean
C0525058 (UMLS CUI [1])
Mental Retardation
Item
mental retardation
boolean
C0025362 (UMLS CUI [1])
Study Subject Participation Status
Item
to have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
boolean
C2348568 (UMLS CUI [1])
Major Depressive Disorder Secondary to Substance Use Disorders | Major Depressive Disorder Secondary to Illness Somatic
Item
mdd secondary to substance abuse or somatic illness
boolean
C1269683 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,3])
C1269683 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0221423 (UMLS CUI [2,3])
C2986476 (UMLS CUI [2,4])
Depressive episode Duration
Item
actual depressive episode with <4 weeks or >12 months of length
boolean
C0349217 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Selective Serotonin Reuptake Inhibitors Quantity | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) Quantity | Selective Serotonin Reuptake Inhibitors augmented | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) augmented | Antidepressive Agents Intravenous | Transcranial magnetic stimulation | Electroconvulsive Therapy | Monoamine Oxidase Inhibitors
Item
current treatment with >1 ssri/srni or previous treatment with >1 ssri/srni, augmentation treatment with ssri/srni, intravenous antidepressant treatment, tms, ect or mao
boolean
C0360105 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1579361 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0360105 (UMLS CUI [3,1])
C0205217 (UMLS CUI [3,2])
C1579361 (UMLS CUI [4,1])
C0205217 (UMLS CUI [4,2])
C0003289 (UMLS CUI [5,1])
C1522726 (UMLS CUI [5,2])
C0436548 (UMLS CUI [6])
C0013806 (UMLS CUI [7])
C0026457 (UMLS CUI [8])